Sveinbjarnarson, Bjarki Freyr
Schmitz, Lisa
Arnardottir, Erna Sif
Islind, Anna Sigridur
Funding for this research was provided by:
European Union (965417)
Article History
Accepted: 9 March 2023
First Online: 10 April 2023
Declarations
:
: Dr. Arnardottir discloses lecture fees from Nox Medical, Philips, ResMed, Jazz Pharmaceuticals, Linde Healthcare, Alcoa—Fjardaral, Visitor (Novo Nordisk), and Wink Sleep. She is also a member of the Philips Sleep Medicine & Innovation Medical Advisory Board. Mr. Sveinbjarnarson discloses fees from Alcoa – Fjardaral and Reykjavikurborg. The other authors declare that they have no conflict of interest.
: This article does not contain any data from studies with human or animal subjects performed. The authors got ethical approval and informed consent before volunteers tested the digital platform.